Journal International Journal COPD Article Designation Original Research Year 2016 Volume 11 DOI 120555 Running head verso Chen et al Running head recto Neuromuscular electrical stimulation COPD International Journal COPD Open access Full Text article Dovepress open access scientific medical research O rIg In l s e rCh effectiveness neuromuscular electrical stimulation rehabilitation moderatetosevere COPD metaanalysis rongchang Chen 1 Xiaoying li 1 lili guan 1 Bingpeng guo 1 Weiliang Wu1 Ziqing Zhou1 Yating huo 1 Xin Chen2 luqian Zhou 1 1state Key laboratory respiratory Disease guangzhou Institute respiratory Disease First affiliated hospital guangzhou Medical University 2Zhujiang hospital southern Medical University guangzhou Peoples republic China These authors contributed equally work Correspondence luqian Zhou state Key laboratory respiratory Disease guangzhou Institute Respiratory Disease First Affiliated hospital guangzhou Medical University 151 Yanjiang road guangzhou guangdong 510120 Peoples republic China Tel 86 156 2223 6759 Fax 86 20 8306 2882 email zhlx09163com Purpose Patients COPD experience skeletal muscle dysfunction For unable unwilling undertake physical training neuromuscular electrical stimulation NMES provide alternative method rehabilitation The purpose metaanalysis investigate controversial topic therapy effective patients moderatetosevere COPD Patients methods We pooled data trials published January 9 2002 January 4 2016 PubMed Embase Cochrane Central Register Controlled Trials Google Scholar relevant websites randomized controlled trials In trials patients moderatetosevere COPD randomly allocated receive NMES Primary outcomes quadricep strength exercise capacity The secondary outcome healthrelated quality life Results We extracted data 276 patients NMES contributed statistically improved quadricep strength standardized mean difference 112 95 confidence interval CI 064159 I254 P000001 exercise capacity including longer exercise distance weighted mean difference 5153 95 CI 20138293 I290 P0001 longer exercise endur ance standardized mean difference 111 95 CI 014208 I285 P002 There significant difference St Georges Respiratory Questionnaire scores weighted mean differ ence 007 95 CI 244 230 I256 P095 Conclusion NMES appears effectual means enhancing quadricep strength exercise capacity moderatetosevere COPD patients Further research demanded clarify effect outcomes determine optimal parameters NMES program Keywords neuromuscular electrical stimulation chronic obstructive pulmonary disease quadriceps muscle strength exercise capacity Introduction COPD major cause morbidity mortality worldwide leads significant economic social burden It predicted thirdleading cause death 202013 It recognized COPD characteristic inspiratory muscle fatigue skeletal muscle deconditioning associated reduced quality life premature mortality4 It established physical respiratory muscle training beneficial patient rehabilitation COPD physical training especially considered best treatments available enhancing limbmuscle function157 A recent study showed physical training prevent cognitive decline asso ciated comorbidities male patients COPD8 Indeed advancedstage COPD submit manuscript wwwdovepresscom Dovepress httpdxdoiorg102147COPDS120555 International Journal COPD 201611 29652975 2965 2016 Chen et al This work published licensed Dove Medical Press Limited The terms license available httpswwwdovepresscomtermsphp incorporate Creative Commons Attribution Non Commercial unported v30 License httpcreativecommonsorglicensesbync30 By accessing work accept Terms Noncommercial uses work permitted permission Dove Medical Press Limited provided work properly attributed For permission commercial use work paragraphs 42 5 Terms httpswwwdovepresscomtermsphp Chen et al Dovepress patients frail tolerate physical training intense breathlessness rest minimum exertion9 Neuromuscular electrical stimulation NMES emerging new rehabilitation modality evoke dyspnea obtain benefit patients unable participate traditional rehabilitation program Also inten sively applied healthy people athletes curative care rehabilitation preventing deconditioning10 Previous studies1120 reached consistent conclu sions metaanalysis21 published 2014 draw equivo cal findings effects NMES moderatetosevere COPD Also largerscale higherquality trials2228 published recent years performed metaanalysis investigate effects NMES patients Patients methods search strategy We searched PubMed Embase Cochrane Central Register Controlled Trials Google Scholar relevant websites detect randomized controlled trials RCTs published June 2016 accordance Preferred Reporting Items Systematic Reviews MetaAnalyses guidelines2931 Search terms chronic obstructive pulmonary disease neuromuscular electrical stimulation corresponding Medical Subject Headings terms Studies filtered human subjects RCTs published trials written English included We excluded studies comparisons NMES duplicated data study selection The inclusive selection criteria RCTs investigating role NMES patients moderatetosevere COPD predefined program NMES applied lower limbs unstimulated treatment sham stimulation defined control group primary outcome quadricep strength exercise capacity defined moving distance endurance time The secondary outcome St Georges Respiratory Questionnaire SGRQ score32 The criteria complied PICO patientproblempopulation intervention comparison controlcomparator outcomes principles For articles reported publications version metaanalysis Abstracts published merely academic conferences website materials excluded Data extraction Two investigators XL LG assessed title abstract eligibility In cases discordance investigator BG participated discussion reach final consensus For studies met inclusion criteria papers obtained analysis Information related trial design characteristics patients relevant results noted according redesigned form We recorded author year patient numbers age sex body mass index forced expiratory volume 1 second stage COPD experi mental control interventions type intervention pulse duration pulse frequency duty cycle intensity current training intensity session time duration weeks outcome parameters results When data insuf ficient inapplicable attempted contact authors email formula2931 convert available data Outcomes Outcomes assigned categories according compa rable features representation The preestablished primary outcome quadricep strength exercise capacity Quadricep strength measured methods including isokinetic quadricep peak torque maximum voluntary contraction authordefined score Exercise capacity primarily 6minute walk test 6MWT33 shuttle walk test SWT3435 constantwork test CWT36 pooled exercise distance endurance time tests The prespecified secondary outcome healthrelated life quality measured SGRQ Data analysis Metaanalyses RevMan 53 software Cochrane Collaboration London UK Weighted mean difference WMD standardized mean difference SMD 95 confidence interval CI considered sum mary statistics derived comparison NMES rehabilitation methods SMD utilized studies reported different units scales outcome To account betweentrial differences mixedeffect modeling random effect parameters anticipated heterogeneity NMES method ology including different stimulating parameters different durations therapy diverse study designs study populations Heterogeneity studies tested I2 statistic I2 values 25 2550 50 indicated low moderate high heterogeneity respectively37 Potential heterogeneity sources identi fied sensitivity analyses conducted eliding study successively comparing influence study overall pooled estimate I250 Funnel plots constructed owing limited number 10 stud ies included analysis For primary outcome exercise capacity subgroup analyses performed based 2966 submit manuscript wwwdovepresscom Dovepress International Journal COPD 201611 Dovepress neuromuscular electrical stimulation COPD methods exercise test 6MWT SWT CWT Data presented means standard deviation tailed Pvalue 005 considered statistically significant The overall treatment effect compared minimum clinically important difference MCID evaluation bias quality assessment Freedom bias evaluated study accordance basis methodological domains2931 adequacy randomsequence generation allocation concealment attrition bias reporting bias biases Two authors BG XL reviewed studies assigned value high low unclear The methodological quality identified trials scored independently GRADE Grades Recommendation Assessment Development Evaluation system3839 The GRADE classifies levels high moderate low low terms quality evidence This approach book reviews quality evidence based items study limitations inconsistency results indirectness evidence imprecision reporting bias For purpose assessing reliability grade quality classification selected articles independently assessed investigators divergences resolved investigator GB Results articles retrieved characteristics included trials Primary literature searches included 370 articles 62 remained exclusion duplicates Following screen ing titles abstracts 20 studies removed owing unrelated content 17 studies RCTs Of 25 fulltext citations studies 276 participants fulfilled inclusive criteria reviewed For papers excluded analy sis study design101315164043 fact stimulation acupuncture4447 three112428 insufficient inapplicable data one25 reported group participants paper26 Figure 1 describes different phase search process The pooled articles published 2002 2016 By pooling data trials 139 assigned NMES intervention population 137 assigned control population The characteristics participants interventions main results extracted corresponding studies shown Table 1 NMES applied quadriceps cid81 cid82 cid76 cid87 cid68 cid70 cid76 cid73 cid76 cid87 cid81 cid72 cid71 cid44 cid76 cid74 cid81 cid81 cid72 cid72 cid85 cid70 cid54 cid92 cid87 cid76 cid79 cid76 cid69 cid74 cid76 cid76 cid79 cid40 cid71 cid72 cid71 cid88 cid79 cid70 cid81 cid44 cid53cid72cid70cid82cid85cid71cid86cid3cid76cid71cid72cid81cid87cid76cid73cid76cid72cid71cid3cid87cid75cid85cid82cid88cid74cid75 cid71cid68cid87cid68cid69cid68cid86cid72cid3cid86cid72cid68cid85cid70cid75cid76cid81cid74 cid11cid81cid32cid20cid24cid23cid12 cid36cid71cid71cid76cid87cid76cid82cid81cid68cid79cid3cid85cid72cid70cid82cid85cid71cid86cid3cid76cid71cid72cid81cid87cid76cid73cid76cid72cid71 cid87cid75cid85cid82cid88cid74cid75cid3cid82cid87cid75cid72cid85cid3cid86cid82cid88cid85cid70cid72cid86 cid11cid81cid32cid21cid20cid25cid12 cid53cid72cid70cid82cid85cid71cid86cid3cid68cid73cid87cid72cid85cid3cid71cid88cid83cid79cid76cid70cid68cid87cid72cid86cid3cid85cid72cid80cid82cid89cid72cid71 cid11cid81cid32cid25cid21cid12 cid53cid72cid70cid82cid85cid71cid86cid3cid86cid70cid85cid72cid72cid81cid72cid71 cid11cid81cid32cid21cid24cid12 cid53cid72cid70cid82cid85cid71cid86cid3cid72cid91cid70cid79cid88cid71cid72cid71 cid11cid81cid32cid22cid26cid12 cid20cid25cid3cid41cid88cid79cid79cid16cid87cid72cid91cid87cid3cid68cid85cid87cid76cid70cid79cid72cid86cid3cid72cid91cid70cid79cid88cid71cid72cid71 cid90cid76cid87cid75cid3cid85cid72cid68cid86cid82cid81cid86cid29 cid3 cid23cid3cid55cid85cid72cid68cid87cid80cid72cid81cid87cid86cid3cid90cid72cid85cid72 cid3 cid68cid70cid88cid83cid88cid81cid70cid87cid88cid85cid72 cid3 cid27cid3cid54cid87cid88cid71cid92cid3cid71cid72cid86cid76cid74cid81 cid3 cid22cid3cid49cid82cid3cid85cid72cid84cid88cid76cid85cid72cid71cid3cid71cid68cid87cid68 cid3 cid20cid3cid53cid72cid71cid88cid83cid79cid76cid70cid68cid87cid76cid89cid72cid3cid83cid68cid85cid87cid76cid70cid76cid83cid68cid81cid87cid86 cid41cid88cid79cid79cid16cid87cid72cid91cid87cid3cid68cid85cid87cid76cid70cid79cid72cid86cid3cid68cid86cid86cid72cid86cid86cid72cid71 cid73cid82cid85cid3cid72cid79cid76cid74cid76cid69cid76cid79cid76cid87cid92 cid11cid81cid32cid28cid12 cid54cid87cid88cid71cid76cid72cid86cid3cid76cid81cid70cid79cid88cid71cid72cid71cid3cid76cid81 cid84cid88cid68cid79cid76cid87cid68cid87cid76cid89cid72cid3cid86cid92cid81cid87cid75cid72cid86cid76cid86 cid11cid81cid32cid28cid12 cid54cid87cid88cid71cid76cid72cid86cid3cid76cid81cid70cid79cid88cid71cid72cid71cid3cid76cid81 cid84cid88cid68cid81cid87cid76cid87cid68cid87cid76cid89cid72cid3cid86cid92cid81cid87cid75cid72cid86cid76cid86 cid11cid80cid72cid87cid68cid16cid68cid81cid68cid79cid92cid86cid76cid86cid12 cid11cid81cid32cid28cid12 Figure 1 Studyselection flowchart International Journal COPD 201611 submit manuscript wwwdovepresscom Dovepress 2967 Chen et al Dovepress Table 1 Characteristics randomized controlled trials included metaanalysis Study year Number patients mf Grade Stage BMI kgm2 NMESsham Age years NMESsham FEV1 NMESsham Study group n NMES group Control group Study design Training protocol NMES parameters Outcomes Bourjeilyhabr et al19 2002 18 108 Moderate tosevere stable COPD 262271 585615 356407 nMes 9 control 9 6 week 3 sessionsweek 20 minper session Frequency 50 hz pulse sWT quadriceps strength Control sham nMes rCT doubleblind duration na intensity isokinetic peak torque instruction electrode position stimulation neder et al20 2002 15 96 Moderate tosevere stable COPD 248256 66665 38395 nMes 9 control 6 Quadriceps strength peak Usual care rCT doubleblind duration 300400 intensity torque exercise endurance Zanotti et al18 2003 Vivodtzev et al17 2006 Vivodtzev et al12 2012 sillen et al2526 2014 24 177 na stable COPD ICU 245224 662645 na nMes Ur 12 Ur 12 4 week 5 sessionsweek Frequency 835 hz pulse Peripheral muscle strength alM rCT doubleblind 17 116 severe stable COPD 18118 5968 2734 nMes Ur 9 Ur 8 4 week 4 sessionsweek Frequency 35 hz pulse Quadriceps strength MVC 4 days week alMs rCT singleblind 30 minper session duration 400 intensity 6MWT dyspnoea 20 137 severe stable COPD 2121 7068 3430 nMes 12 sham 8 6 week 5 sessionsweek Frequency 50 hz pulse Quadriceps strength sham Frequency 5 hz rCT doubleblind 81 4338 severe stable COPD 241249 64464 3333 hFnMes 41 strength training 40 Vieira et al27 2014 20 200 Moderate tosevere stable COPD 2747276 563564 365396 nMes 11 control 9 8 week 5 sessionsweek Frequency 50 hz pulse 6MWT dyspnoea exercise sham nMes rCT doubleblind Tasdemir et al23 2015 27 243 Moderate tosevere stable COPD 251274 621629 29425 nMes cPr 13 sham cPr 14 Maddocks et al22 2016 52 2131 severe stable COPD 257278 7069 308307 nMes 25 placebo 27 6 week 7 sessionsweek Frequency 50 hz pulse 6MWT quadriceps muscle Placebo nMes I 020 ma rCT doubleblind 30 minper session duration 350 intensity max strength MVC sgrQ insufficient elicit tetanic 6 week 5 sessionsweek 15 min 1st week 30 min 30 minper session 56795 ma duty cycle 02 s on13 seconds Frequency 50 hz pulse 1020 ma 100 ma duty cycle 2 s on18 s 10 s on30 s duration 250350 intensity na duty cycle na max tolerable 2146 ma duty cycle 47 35 min stimulation duration 400 intensity exercise endurance sWT pulse duration 100 quadriceps followed 25 min max tolerable 2031 ma dyspnoea stimulation calf 8 week 5 sessionsweek duty cycle 2 s on16 s Frequency 75 hz pulse 18 minper session duration 400 intensity max isokinetic quadriceps tolerable duty cycle na muscle strength 6MWT exercise endurance dyspnoea sgrQ Quadriceps muscle strength strength training rCT singleblind 60 minper session duration 300400 intensity endurance sgrQ instruction electrode position stimulation max tolerable 1520 ma 100 ma duty cycle 2 s on18 s 10 s on30 s 10 week 2 sessionsweek Frequency 50 hz pulse sWT dyspnoea quadriceps cPr mainly exercise rCT doubleblind 20 minper session duration 300 intensity muscle strength exercise training sham nMes max individual tolerance endurance MrC sgrQ Intensive 5 ma 29433581 ma duty cycle 10 s on20 s insufficient elicit tetanic muscular contraction tolerable duty cycle 2 s on15 s 10 s on15 s muscular contraction Notes Data shown mean sD indicated percentage predicted value Abbreviations BMI body mass index FeV1 forced expiratory volume 1 second nMes neuromuscular electrical stimulation na available COPD chronic obstructive pulmonary disease Ur usual rehabilitation hFnMes high frequency neuromuscular electrical stimulation sWT shuttlewalk test 6MWT 6minute walk test MVC maximum voluntary contraction sgrQ st georges respiratory Questionnaire rCT randomized controlled trial alMs active limb mobilizations M male F female ICU intensive care unit cPr comprehensive pulmonary rehabilitation MrC Medical research Council scale I intensive accessory respiratory muscles27 Stimulationpulse duration 250400 μs stimulation frequency ranged 8 120 Hz Intensities ranged 10 100 mA gradually increased entire stimulation according patients individual tolerance riskofbias assessment quality assessment The riskofbias studies shown Figure 2 Inad equate description data randomization protocol blinding strategy reported RCTs two2226 led unclear risk bias On hand qualityassessment items presented Figures 3 4 Evidence based RCTs assumed highquality evidence issues reduce confidence study These included limitations study design inconsistency indirectness imprecision publication bias48 For pooled studies kept original conclusion study quality high violation criteria49 2968 submit manuscript wwwdovepresscom Dovepress International Journal COPD 201611 Table 1 Characteristics randomized controlled trials included metaanalysis Study year Number Grade Stage BMI kgm2 Age years FEV1 Study patients mf NMESsham NMESsham NMESsham group n Bourjeilyhabr 18 108 Moderate stable COPD 262271 585615 356407 nMes 9 control 9 et al19 2002 tosevere neder et al20 15 96 Moderate stable COPD 248256 66665 38395 nMes 9 control 6 2002 2003 2006 2012 2014 2014 2015 2016 tosevere ICU tosevere tosevere Zanotti et al18 24 177 na stable COPD 245224 662645 na nMes Ur 12 Ur 12 Vivodtzev et al17 17 116 severe stable COPD 18118 5968 2734 nMes Ur 9 Ur 8 Vivodtzev et al12 20 137 severe stable COPD 2121 7068 3430 nMes 12 sham 8 sillen et al2526 81 4338 severe stable COPD 241249 64464 3333 hFnMes 41 strength training 40 Vieira et al27 20 200 Moderate stable COPD 2747276 563564 365396 nMes 11 control 9 Tasdemir et al23 27 243 Moderate stable COPD 251274 621629 29425 Maddocks et al22 52 2131 severe stable COPD 257278 7069 308307 nMes cPr 13 sham cPr 14 nMes 25 placebo 27 Notes Data shown mean sD indicated percentage predicted value Abbreviations BMI body mass index FeV1 forced expiratory volume 1 second nMes neuromuscular electrical stimulation na available COPD chronic obstructive pulmonary disease Ur usual rehabilitation hFnMes high frequency neuromuscular electrical stimulation sWT shuttlewalk test 6MWT 6minute walk test MVC maximum voluntary contraction sgrQ st georges respiratory Questionnaire rCT randomized controlled trial alMs active limb mobilizations M male F female ICU intensive care unit cPr comprehensive pulmonary rehabilitation MrC Medical research Council scale I intensive Dovepress NMES group neuromuscular electrical stimulation COPD Control group Study design Training protocol NMES parameters Outcomes 6 week 3 sessionsweek 20 minper session 6 week 5 sessionsweek 15 min 1st week 30 min 4 week 5 sessionsweek 30 minper session 4 week 4 sessionsweek 30 minper session 6 week 5 sessionsweek 35 min stimulation quadriceps followed 25 min stimulation calf 8 week 5 sessionsweek 18 minper session 8 week 5 sessionsweek 60 minper session 10 week 2 sessionsweek 20 minper session 6 week 7 sessionsweek 30 minper session Frequency 50 hz pulse duration na intensity 56795 ma duty cycle 02 s on13 seconds Frequency 50 hz pulse duration 300400 intensity 1020 ma 100 ma duty cycle 2 s on18 s 10 s on30 s Frequency 835 hz pulse duration 250350 intensity na duty cycle na Frequency 35 hz pulse duration 400 intensity max tolerable 2146 ma duty cycle 47 Frequency 50 hz pulse duration 400 intensity max tolerable 2031 ma duty cycle 2 s on16 s Frequency 75 hz pulse duration 400 intensity max tolerable duty cycle na Frequency 50 hz pulse duration 300400 intensity max tolerable 1520 ma 100 ma duty cycle 2 s on18 s 10 s on30 s Frequency 50 hz pulse duration 300 intensity max individual tolerance 29433581 ma duty cycle 10 s on20 s Frequency 50 hz pulse duration 350 intensity max tolerable duty cycle 2 s on15 s 10 s on15 s sWT quadriceps strength isokinetic peak torque Control sham nMes instruction electrode position stimulation rCT doubleblind Quadriceps strength peak torque exercise endurance Usual care rCT doubleblind Peripheral muscle strength alM rCT doubleblind Quadriceps strength MVC 6MWT dyspnoea 4 days week alMs rCT singleblind Quadriceps strength exercise endurance sWT dyspnoea Quadriceps muscle strength isokinetic quadriceps muscle strength 6MWT exercise endurance dyspnoea sgrQ 6MWT dyspnoea exercise endurance sgrQ sham Frequency 5 hz pulse duration 100 rCT doubleblind strength training rCT singleblind sham nMes instruction electrode position stimulation rCT doubleblind sWT dyspnoea quadriceps muscle strength exercise endurance MrC sgrQ 6MWT quadriceps muscle strength MVC sgrQ cPr mainly exercise training sham nMes Intensive 5 ma insufficient elicit tetanic muscular contraction Placebo nMes I 020 ma insufficient elicit tetanic muscular contraction rCT doubleblind rCT doubleblind Primary outcomes Results RCTs n276 obtained assess effects NMES patients moderatetosevere COPD Aggregate analyses showed application NMES linked significantly enhanced quadricep strength SMD 112 95 CI 064159 I254 P000001 Figure 5 There benefit NMES improving exercise capacity evaluated longer exercise distance traveled WMD 5153 95 CI 20138293 I2 differences 0 P0001 Figure 6 longer exercise endurance overall 90 I2 subgroup subgroup overall 85 I2 time SMD 111 95 CI 014208 I2 differences 816 P002 Figure 7 We failed draw funnel plots explore potential source heterogeneity number RCTs included fewer 10 We carried subgroup analyses investigate impact NMES exercise capacity different exercise tests For 6MWT walking distance significantly improved WMD 3727 95 CI 31824273 I20 P000001 For CWT endurance time increased significantly SMD 178 95 CI 116240 I235 P000001 For SWT International Journal COPD 201611 submit manuscript wwwdovepresscom Dovepress 2969 Chen et al Dovepress cid53cid68cid81cid71cid82cid80cid16cid86cid72cid84cid88cid72cid81cid70cid72cid3cid74cid72cid81cid72cid85cid68cid87cid76cid82cid81cid3cid11cid86cid72cid79cid72cid70cid87cid76cid82cid81cid3cid69cid76cid68cid86cid12 cid36cid79cid79cid82cid70cid68cid87cid76cid82cid81cid3cid70cid82cid81cid70cid72cid68cid79cid80cid72cid81cid87cid3cid11cid86cid72cid79cid72cid70cid87cid76cid82cid81cid3cid69cid76cid68cid86cid12 cid37cid79cid76cid81cid71cid76cid81cid74cid3cid82cid73cid3cid83cid68cid85cid87cid76cid70cid76cid83cid68cid81cid87cid86cid3cid68cid81cid71cid3cid83cid72cid85cid86cid82cid81cid81cid72cid79cid3cid11cid83cid72cid85cid73cid82cid85cid80cid68cid81cid70cid72cid3cid69cid76cid68cid86cid12 cid37cid79cid76cid81cid71cid76cid81cid74cid3cid82cid73cid3cid82cid88cid87cid70cid82cid80cid72cid3cid68cid86cid86cid72cid86cid86cid80cid72cid81cid87cid3cid11cid71cid72cid87cid72cid70cid87cid76cid82cid81cid3cid69cid76cid68cid86cid12 cid44cid81cid70cid82cid80cid83cid79cid72cid87cid72cid3cid82cid88cid87cid70cid82cid80cid72cid3cid71cid68cid87cid68cid3cid11cid68cid87cid87cid85cid76cid87cid76cid82cid81cid3cid69cid76cid68cid86cid12 cid54cid72cid79cid72cid70cid87cid76cid89cid72cid3cid85cid72cid83cid82cid85cid87cid76cid81cid74cid3cid11cid85cid72cid83cid82cid85cid87cid76cid81cid74cid3cid69cid76cid68cid86cid12 cid50cid87cid75cid72cid85cid3cid69cid76cid68cid86 cid19cid8 cid21cid24cid8 cid24cid19cid8 cid26cid24cid8 cid20cid19cid19cid8 cid47cid82cid90cid3cid85cid76cid86cid78cid3cid82cid73cid3cid69cid76cid68cid86 cid56cid81cid70cid79cid72cid68cid85cid3cid85cid76cid86cid78cid3cid82cid73cid3cid69cid76cid68cid86 cid43cid76cid74cid75cid3cid85cid76cid86cid78cid3cid82cid73cid3cid69cid76cid68cid86 cid21 cid20 cid79 cid68 cid3 cid87 cid72 cid3 cid89 cid72 cid93 cid87 cid71 cid82 cid89 cid57 cid76 cid26 cid20 cid79 cid68 cid3 cid87 cid72 cid3 cid89 cid72 cid93 cid87 cid71 cid82 cid89 cid57 cid76 cid34 cid34 cid14 cid34 cid14 cid14 cid34 cid34 cid34 cid34 cid34 cid14 cid14 cid34 cid22 cid21 cid79 cid68 cid3 cid87 cid72 cid3 cid85 cid76 cid80 cid72 cid71 cid86 cid68 cid55 cid14 cid14 cid14 cid34 cid14 cid14 cid34 cid26 cid21 cid79 cid68 cid3 cid87 cid72 cid3 cid68 cid85 cid76 cid72 cid57 cid76 cid14 cid14 cid14 cid34 cid14 cid14 cid34 cid27 cid20 cid79 cid68 cid3 cid87 cid72 cid3 cid76 cid87 cid87 cid82 cid81 cid68 cid61 cid34 cid34 cid34 cid34 cid14 cid14 cid34 cid25 cid21 cid15 cid24 cid21 cid79 cid68 cid3 cid87 cid72 cid3 cid81 cid72 cid79 cid79 cid76 cid54 cid19 cid21 cid79 cid68 cid3 cid87 cid72 cid3 cid85 cid72 cid71 cid72 cid49 cid14 cid14 cid14 cid14 cid14 cid14 cid34 cid34 cid14 cid14 cid34 cid14 cid14 cid34 cid21 cid21 cid79 cid68 cid3 cid87 cid72 cid3 cid86 cid78 cid70 cid82 cid71 cid71 cid68 cid48 cid14 cid14 cid14 cid14 cid14 cid14 cid34 cid28 cid20 cid79 cid68 cid3 cid87 cid72 cid3 cid85 cid69 cid68 cid43 cid16 cid92 cid79 cid76 cid72 cid77 cid85 cid88 cid82 cid37 cid34 cid14 cid14 cid34 cid14 cid14 cid34 cid53cid68cid81cid71cid82cid80cid16cid86cid72cid84cid88cid72cid81cid70cid72cid3cid74cid72cid81cid72cid85cid68cid87cid76cid82cid81cid3cid11cid86cid72cid79cid72cid70cid87cid76cid82cid81cid3cid69cid76cid68cid86cid12 cid36cid79cid79cid82cid70cid68cid87cid76cid82cid81cid3cid70cid82cid81cid70cid72cid68cid79cid80cid72cid81cid87cid3cid11cid86cid72cid79cid72cid70cid87cid76cid82cid81cid3cid69cid76cid68cid86cid12 cid37cid79cid76cid81cid71cid76cid81cid74cid3cid82cid73cid3cid83cid68cid85cid87cid76cid70cid76cid83cid68cid81cid87cid86cid3cid68cid81cid71cid3cid83cid72cid85cid86cid82cid81cid81cid72cid79cid3cid11cid83cid72cid85cid73cid82cid85cid80cid68cid81cid70cid72cid3cid69cid76cid68cid86cid12 cid37cid79cid76cid81cid71cid76cid81cid74cid3cid82cid73cid3cid82cid88cid87cid70cid82cid80cid72cid3cid68cid86cid86cid72cid86cid86cid80cid72cid81cid87cid3cid11cid71cid72cid87cid72cid70cid87cid76cid82cid81cid3cid69cid76cid68cid86cid12 cid44cid81cid70cid82cid80cid83cid79cid72cid87cid72cid3cid82cid88cid87cid70cid82cid80cid72cid3cid71cid68cid87cid68cid3cid11cid68cid87cid87cid85cid76cid87cid76cid82cid81cid3cid69cid76cid68cid86cid12 cid54cid72cid79cid72cid70cid87cid76cid89cid72cid3cid85cid72cid83cid82cid85cid87cid76cid81cid74cid3cid11cid85cid72cid83cid82cid85cid87cid76cid81cid74cid3cid69cid76cid68cid86cid12 cid50cid87cid75cid72cid85cid3cid69cid76cid68cid86 Figure 2 riskofbias analysis significant improvement distance WMD 6806 95 CI 507 18683 I296 P026 endurance time SMD 028 95 CI 082 138 I270 P062 secondary outcomes For healthrelated quality life results demonstrated NMES improve SGRQ scores WMD 007 95 CI 244 230 I256 P095 Figure 8 We perform sensitivity analyses explore potential sources heterogeneity RCTs included Discussion This pooled analysis data RCTs indicated meaningful findings NMES severe COPD The main findings metaanalysis NMES improved patients quadricep strength exercise capacity particularly range subgroups statistically significant improvement degree health related quality life To knowledge metaanalysis involved largest numbers patients RCTs far12172022232627 The strength quality metaanalysis better fewer patients RCTs reported literature Compared equivocal results Pan et als review21 efficacy NMES conclusion contradictory On premise including larger numbers highquality trials performed subgroup analysis classify evalu ation methodology outcomes In addition use GRADE metaanalysis advantages rating systems48 evaluating methodological quality pooled trials As consider metaanalysis convincing providing evidence favor NMES Quadricep strength enhanced significantly dem onstrated pooled data isokinetic quadricep peak torque 2970 submit manuscript wwwdovepresscom Dovepress International Journal COPD 201611 Dovepress neuromuscular electrical stimulation COPD Figure 3 Quality assessment quadricep strength exercise capacity Abbreviations sMD standardized mean difference CWT constantwork test sWT shuttlewalk test 6MWT 6minute walk test trials19202526 maximum voluntary contraction studies1722 authordefined score seventh report Figure 518 Compared Pan et als review21 included methods evaluation quadricep strength high impact articles2226 published shortly Pan et als paper The baseline level impairment peripheral muscle func tion important impact outcome NMES As subjects varying degrees impairment peripheral function included study reports included reports peripheral muscle weakness The inconsistent inclusion criteria contributed high heterogeneity The severity COPD impact effects NMES In metaanalysis focused COPD patients moderatetosevere flow limitation The study Napolis et al15 excluded included COPD patients lowlevel flow limitation Studies including patients acute exacerbations COPD excluded greater improvement suggested International Journal COPD 201611 submit manuscript wwwdovepresscom Dovepress 2971 Chen et al Dovepress Figure 4 Quality assessment sgrQ Abbreviations SGRQ St Georges Respiratory Questionnaire CI confidence interval GRADE Grades Recommendation Assessment Development Evaluation cid54cid87cid88cid71cid92cid3cid82cid85 cid86cid88cid69cid74cid85cid82cid88cid83 cid49cid48cid40cid54 cid48cid72cid68cid81 cid54cid39 cid55cid82cid87cid68cid79 cid38cid82cid81cid87cid85cid82cid79 cid48cid72cid68cid81 cid54cid39 cid58cid72cid76cid74cid75cid87 cid11cid8cid12 cid55cid82cid87cid68cid79 cid54cid87cid68cid81cid71cid68cid85cid71cid76cid93cid72cid71cid3cid80cid72cid68cid81 cid71cid76cid73cid73cid72cid85cid72cid81cid70cid72cid3cid44cid57cid15cid3cid85cid68cid81cid71cid82cid80cid15 cid28cid24cid8cid3cid38cid44 cid54cid87cid68cid81cid71cid68cid85cid71cid76cid93cid72cid71cid3cid80cid72cid68cid81 cid71cid76cid73cid73cid72cid85cid72cid81cid70cid72cid3cid44cid57cid15cid3cid85cid68cid81cid71cid82cid80cid15 cid28cid24cid8cid3cid38cid44 cid37cid82cid88cid85cid77cid72cid76cid79cid92cid16cid43cid68cid69cid85cid3cid72cid87cid3cid68cid79cid20cid28 cid48cid68cid71cid71cid82cid70cid78cid86cid3cid72cid87cid3cid68cid79cid21cid21 cid49cid72cid71cid72cid85cid3cid72cid87cid3cid68cid79cid21cid19 cid54cid76cid79cid79cid72cid81cid3cid72cid87cid3cid68cid79cid21cid24cid15cid21cid25 cid57cid76cid89cid82cid71cid87cid93cid72cid89cid3cid72cid87cid3cid68cid79cid20cid26 cid61cid68cid81cid82cid87cid87cid76cid3cid72cid87cid3cid68cid79cid20cid27 cid20cid19cid17cid24 cid22cid17cid23cid22 cid21cid26cid17cid23 cid20cid19cid17cid27 cid28cid26 cid21cid17cid20cid25 cid25cid17cid23cid26 cid23cid17cid28cid21 cid20cid28cid17cid24 cid21cid17cid28 cid26cid20 cid20cid17cid19cid21 cid28 cid21cid24 cid28 cid23cid20 cid28 cid20cid21 cid22cid17cid28 cid19cid17cid22cid23 cid24cid17cid21 cid25cid17cid20 cid22cid25 cid20cid17cid21cid24 cid25cid17cid23cid26 cid23cid17cid28cid21 cid20cid28cid17cid24 cid21 cid22cid24 cid19cid17cid26cid24 cid28 cid21cid26 cid25 cid22cid28 cid27 cid20cid21 cid20cid22cid17cid24 cid21cid21cid17cid25 cid20cid20cid17cid25 cid21cid22cid17cid23 cid20cid21cid17cid28 cid20cid24cid17cid28 cid19cid17cid28cid26cid3cid11cid177cid19cid17cid19cid21cid3cid87cid82cid3cid20cid17cid28cid25cid12 cid19cid17cid25cid21cid3cid11cid19cid17cid19cid25cid177cid20cid17cid20cid27cid12 cid20cid17cid19cid26cid3cid11cid177cid19cid17cid19cid24cid3cid87cid82cid3cid21cid17cid21cid19cid12 cid20cid17cid27cid25cid3cid11cid20cid17cid22cid22cid177cid21cid17cid22cid28cid12 cid20cid17cid19cid20cid3cid11cid177cid19cid17cid19cid20cid3cid87cid82cid3cid21cid17cid19cid23cid12 cid19cid17cid28cid27cid3cid11cid19cid17cid20cid22cid177cid20cid17cid27cid23cid12 cid55cid82cid87cid68cid79cid3cid11cid28cid24cid8cid3cid38cid44cid12 cid43cid72cid87cid72cid85cid82cid74cid72cid81cid72cid76cid87cid92cid29cid3τ cid21cid32cid19cid17cid20cid27cid30cid3χ cid21cid32cid20cid19cid17cid26cid25cid15cid3cid71cid73cid32cid24cid3cid11cid51cid32cid19cid17cid19cid25cid12cid30cid3cid44 cid21cid32cid24cid23cid8 cid55cid72cid86cid87cid3cid73cid82cid85cid3cid82cid89cid72cid85cid68cid79cid79cid3cid72cid73cid73cid72cid70cid87cid29cid3cid61cid32cid23cid17cid25cid20cid3cid11cid51cid31cid19cid17cid19cid19cid19cid19cid20cid12 cid20cid19cid24 cid20cid19cid20 cid20cid19cid19 cid20cid17cid20cid21cid3cid11cid19cid17cid25cid23cid177cid20cid17cid24cid28cid12 cid177cid21 cid177cid20 cid19 cid41cid68cid89cid82cid85cid86cid3cid11cid49cid48cid40cid54cid12 cid41cid68cid89cid82cid85cid86cid3cid11cid70cid82cid81cid87cid85cid82cid79cid12 cid20 cid21 Figure 5 Metaanalysis randomized controlled trials evaluating effects nMes quadricep strength Abbreviations NMES neuromuscular electrical stimulation SD standard deviation IV inverse variance CI confidence interval cid54cid87cid88cid71cid92cid3cid82cid85 cid86cid88cid69cid74cid85cid82cid88cid83 cid49cid48cid40cid54 cid48cid72cid68cid81 cid54cid39 cid55cid82cid87cid68cid79 cid38cid82cid81cid87cid85cid82cid79 cid48cid72cid68cid81 cid54cid39 cid58cid72cid76cid74cid75cid87 cid11cid8cid12 cid48cid72cid68cid81cid3cid71cid76cid73cid73cid72cid85cid72cid81cid70cid72cid3cid44cid57cid15 cid85cid68cid81cid71cid82cid80cid15cid3cid28cid24cid8cid3cid38cid44 cid55cid82cid87cid68cid79 cid48cid72cid68cid81cid3cid71cid76cid73cid73cid72cid85cid72cid81cid70cid72cid3cid44cid57cid15 cid85cid68cid81cid71cid82cid80cid15cid3cid28cid24cid8cid3cid38cid44 cid25cid48cid58cid55 cid48cid68cid71cid71cid82cid70cid78cid86cid3cid72cid87cid3cid68cid79cid21cid21 cid54cid76cid79cid79cid72cid81cid3cid72cid87cid3cid68cid79cid21cid24cid15cid21cid25 cid57cid76cid72cid76cid85cid68cid3cid72cid87cid3cid68cid79cid21cid26 cid57cid76cid89cid82cid71cid87cid93cid72cid89cid3cid72cid87cid3cid68cid79cid20cid26 cid54cid88cid69cid87cid82cid87cid68cid79cid3cid11cid28cid24cid8cid3cid38cid44cid12 cid43cid72cid87cid72cid85cid82cid74cid72cid81cid72cid76cid87cid92cid29cid3τ cid21cid32cid19cid17cid19cid30cid3χ cid21cid32cid21cid17cid20cid26cid15cid3cid71cid73cid32cid22cid3cid11cid51 cid32cid19cid17cid24cid23cid12cid30cid3cid44 cid21cid32cid19 cid55cid72cid86cid87cid3cid73cid82cid85cid3cid82cid89cid72cid85cid68cid79cid79cid3cid72cid73cid73cid72cid70cid87cid29cid3cid61cid32cid20cid22cid17cid22cid28cid3cid11cid51 cid31cid19cid17cid19cid19cid19cid19cid20cid12 cid23cid22cid17cid26cid28 cid20cid23 cid24cid26cid17cid27cid28 cid23cid19 cid177cid24cid17cid26 cid21cid28 cid19cid17cid27 cid22cid19 cid21cid28cid17cid28 cid25cid25 cid26cid24cid17cid26 cid25cid22 cid21cid24 cid23cid20 cid20cid20 cid28 cid27cid25 cid23cid22cid17cid26cid28 cid20cid21 cid24cid26cid17cid27cid28 cid22cid27 cid21cid26 cid22cid28 cid28 cid27 cid27cid22 cid20cid24cid17cid27 cid20cid26cid17cid22 cid20cid20cid17cid28 cid20cid23cid17cid19 cid24cid28cid17cid19 cid22cid24cid17cid25cid19cid3cid11cid20cid20cid17cid26cid27cid177cid24cid28cid17cid23cid21cid12 cid22cid26cid17cid19cid19cid3cid11cid22cid20cid17cid21cid28cid177cid23cid21cid17cid26cid20cid12 cid26cid23cid17cid28cid19cid3cid11cid21cid22cid17cid28cid19cid177cid20cid21cid24cid17cid28cid19cid12 cid22cid22cid17cid19cid19cid3cid11cid177cid23cid17cid20cid19cid3cid87cid82cid3cid26cid19cid17cid20cid19cid12 cid22cid26cid17cid21cid26cid3cid11cid22cid20cid17cid27cid21cid177cid23cid21cid17cid26cid22cid12 cid54cid58cid55 cid37cid82cid88cid85cid77cid72cid76cid79cid92cid16cid43cid68cid69cid85cid3cid72cid87cid3cid68cid79cid20cid28 cid20cid22cid17cid19 cid55cid68cid86cid71cid72cid80cid76cid85cid3cid72cid87cid3cid68cid79cid21cid22 cid20cid24cid17cid21 cid57cid76cid89cid82cid71cid87cid93cid72cid89cid3cid72cid87cid3cid68cid79cid20cid21 cid20cid21cid17cid27 cid23cid20cid17cid19 cid54cid88cid69cid87cid82cid87cid68cid79cid3cid11cid28cid24cid8cid3cid38cid44cid12 cid43cid72cid87cid72cid85cid82cid74cid72cid81cid72cid76cid87cid92cid29cid3τ cid21cid32cid20cid19cid15cid25cid19cid25cid17cid19cid24cid30cid3χ cid21cid32cid24cid25cid17cid26cid22cid15cid3cid71cid73cid32cid21cid3cid11cid51 cid31cid19cid17cid19cid19cid19cid19cid20cid12cid30cid3cid44 cid21cid32cid28cid25cid8 cid55cid72cid86cid87cid3cid73cid82cid85cid3cid82cid89cid72cid85cid68cid79cid79cid3cid72cid73cid73cid72cid70cid87cid29cid3cid61cid32cid20cid17cid20cid21cid3cid11cid51 cid32cid19cid17cid21cid25cid12 cid23cid26cid17cid21cid20 cid22cid22cid17cid25 cid21cid26 cid23cid26cid17cid21cid20 cid23cid20cid17cid27 cid26cid21 cid25cid27cid17cid27 cid22cid27cid17cid23 cid20cid26cid23 cid19 cid25cid28cid17cid21 cid24 cid28 cid20cid22 cid20cid21 cid22cid23 cid28 cid20cid23 cid27 cid22cid20 cid55cid82cid87cid68cid79cid3cid11cid28cid24cid8cid3cid38cid44cid12 cid43cid72cid87cid72cid85cid82cid74cid72cid81cid72cid76cid87cid92cid29cid3τ cid21cid32cid20cid15cid23cid26cid25cid17cid25cid21cid30cid3χ cid21cid32cid24cid27cid17cid28cid19cid15cid3cid71cid73cid32cid25cid3cid11cid51 cid31cid19cid17cid19cid19cid19cid19cid20cid12cid30cid3cid44 cid21cid32cid28cid19cid8 cid55cid72cid86cid87cid3cid73cid82cid85cid3cid82cid89cid72cid85cid68cid79cid79cid3cid72cid73cid73cid72cid70cid87cid29cid3cid61cid32cid22cid17cid21cid21cid3cid11cid51 cid32cid19cid17cid19cid19cid20cid12 cid55cid72cid86cid87cid3cid73cid82cid85cid3cid86cid88cid69cid74cid85cid82cid88cid83cid3cid71cid76cid73cid73cid72cid85cid72cid81cid70cid72cid86cid29cid3χ cid21cid32cid19cid17cid21cid25cid15cid3cid71cid73 cid32cid20cid3cid11cid51 cid32cid19cid17cid25cid20cid12cid30cid3cid44 cid21cid32cid19 cid20cid21cid19 cid20cid20cid23 cid20cid19cid19 cid25cid27cid17cid27cid19cid3cid11cid21cid24cid17cid20cid27cid177cid20cid20cid21cid17cid23cid21cid12 cid177cid22cid19cid17cid27cid19cid3cid11cid177cid24cid28cid17cid24cid23cid3cid87cid82cid3cid177cid21cid17cid19cid25cid12 cid20cid25cid28cid17cid19cid19cid3cid11cid20cid21cid23cid17cid20cid26cid177cid21cid20cid22cid17cid27cid22cid12 cid25cid27cid17cid19cid25cid3cid11cid177cid24cid19cid17cid26cid19cid3cid87cid82cid3cid20cid27cid25cid17cid27cid22cid12 cid24cid20cid17cid24cid22cid3cid11cid21cid19cid17cid20cid22cid177cid27cid21cid17cid28cid22cid12 cid177cid20cid19cid19 cid177cid21cid19cid19 cid41cid68cid89cid82cid85cid86cid3cid11cid49cid48cid40cid54cid12 cid19 cid20cid19cid19 cid21cid19cid19 cid41cid68cid89cid82cid85cid86cid3cid11cid70cid82cid81cid87cid85cid82cid79cid12 Figure 6 Metaanalysis randomized controlled trials evaluating effects nMes exercise distance Abbreviations NMES neuromuscular electrical stimulation SD standard deviation IV inverse variance CI confidence interval 6MWT 6minute walk test SWT shuttle walk test 2972 submit manuscript wwwdovepresscom Dovepress International Journal COPD 201611 Dovepress neuromuscular electrical stimulation COPD cid54cid87cid88cid71cid92cid3cid82cid85 cid86cid88cid69cid74cid85cid82cid88cid83 cid49cid48cid40cid54 cid48cid72cid68cid81 cid54cid39 cid55cid82cid87cid68cid79 cid38cid82cid81cid87cid85cid82cid79 cid48cid72cid68cid81 cid54cid39 cid58cid72cid76cid74cid75cid87 cid11cid8cid12 cid55cid82cid87cid68cid79 cid54cid87cid68cid81cid71cid68cid85cid71cid76cid93cid72cid71cid3cid80cid72cid68cid81 cid71cid76cid73cid73cid72cid85cid72cid81cid70cid72cid3cid44cid57cid15cid3cid85cid68cid81cid71cid82cid80cid15 cid28cid24cid8cid3cid38cid44 cid54cid87cid68cid81cid71cid68cid85cid71cid76cid93cid72cid71cid3cid80cid72cid68cid81 cid71cid76cid73cid73cid72cid85cid72cid81cid70cid72cid3cid44cid57cid15cid3cid85cid68cid81cid71cid82cid80cid15 cid28cid24cid8cid3cid38cid44 cid38cid58cid55 cid49cid72cid71cid72cid85cid3cid72cid87cid3cid68cid79cid21cid19 cid54cid76cid79cid79cid72cid81cid3cid72cid87cid3cid68cid79cid21cid24cid15cid21cid25 cid57cid76cid72cid76cid85cid68cid3cid72cid87cid3cid68cid79cid21cid26 cid54cid88cid69cid87cid82cid87cid68cid79cid3cid11cid28cid24cid8cid3cid38cid44cid12 cid43cid72cid87cid72cid85cid82cid74cid72cid81cid72cid76cid87cid92cid29cid3τ cid21cid32cid19cid17cid20cid20cid30cid3χ cid21cid32cid22cid17cid19cid26cid15cid3cid71cid73cid32cid21cid3cid11cid51cid32cid19cid17cid21cid21cid12cid30cid3cid44 cid21cid32cid22cid24cid8 cid55cid72cid86cid87cid3cid73cid82cid85cid3cid82cid89cid72cid85cid68cid79cid79cid3cid72cid73cid73cid72cid70cid87cid29cid3cid61cid32cid24cid17cid25cid23cid3cid11cid51cid31cid19cid17cid19cid19cid19cid19cid20cid12 cid177cid19cid17cid24 cid25cid28 cid19cid17cid21 cid21cid17cid26cid26 cid24cid27 cid20cid17cid24cid24 cid21cid17cid26cid26 cid22cid19 cid20cid17cid24cid24 cid22cid17cid28 cid20cid26cid20 cid21cid17cid21cid20 cid28 cid23cid20 cid20cid20 cid25cid20 cid54cid58cid55 cid55cid68cid86cid71cid72cid80cid76cid85cid3cid72cid87cid3cid68cid79cid21cid22 cid57cid76cid89cid82cid71cid87cid93cid72cid89cid3cid72cid87cid3cid68cid79cid20cid21 cid54cid88cid69cid87cid82cid87cid68cid79cid3cid11cid28cid24cid8cid3cid38cid44cid12 cid43cid72cid87cid72cid85cid82cid74cid72cid81cid72cid76cid87cid92cid29cid3τ cid21cid32cid19cid17cid23cid23cid30cid3χ cid21cid32cid22cid17cid22cid21cid15cid3cid71cid73cid32cid20cid3cid11cid51cid32cid19cid17cid19cid26cid12cid30cid3cid44 cid21cid32cid26cid19cid8 cid55cid72cid86cid87cid3cid73cid82cid85cid3cid82cid89cid72cid85cid68cid79cid79cid3cid72cid73cid73cid72cid70cid87cid29cid3cid61cid32cid19cid17cid23cid28cid3cid11cid51cid32cid19cid17cid25cid21cid12 cid20cid24cid21cid17cid24cid23 cid21cid22cid28 cid21cid23cid20cid17cid20cid25 cid177cid20 cid20cid26cid25cid17cid23cid25 cid21cid25cid20cid17cid28cid27 cid23cid23cid28cid17cid19cid22 cid21cid25cid20cid17cid28cid27 cid20cid22 cid20cid21 cid21cid24 cid25 cid22cid28 cid28 cid24cid23 cid20cid23 cid27 cid21cid21 cid55cid82cid87cid68cid79cid3cid11cid28cid24cid8cid3cid38cid44cid12 cid43cid72cid87cid72cid85cid82cid74cid72cid81cid72cid76cid87cid92cid29cid3τ cid21cid32cid20cid17cid19cid20cid30cid3χ cid21cid32cid21cid25cid17cid22cid22cid15cid3cid71cid73cid32cid23cid3cid11cid51cid31cid19cid17cid19cid19cid19cid20cid12cid30cid3cid44 cid21cid32cid27cid24cid8 cid55cid72cid86cid87cid3cid73cid82cid85cid3cid82cid89cid72cid85cid68cid79cid79cid3cid72cid73cid73cid72cid70cid87cid29cid3cid61cid32cid21cid17cid21cid24cid3cid11cid51cid32cid19cid17cid19cid21cid12 cid55cid72cid86cid87cid3cid73cid82cid85cid3cid86cid88cid69cid74cid85cid82cid88cid83cid3cid71cid76cid73cid73cid72cid85cid72cid81cid70cid72cid86cid29cid3χ cid21cid32cid24cid17cid23cid21cid15cid3cid71cid73cid32cid20cid3cid11cid51cid32cid19cid17cid19cid21cid12cid30cid3cid44 cid21cid32cid27cid20cid17cid25cid8 cid26cid25 cid27cid25 cid20cid26cid17cid25 cid21cid21cid17cid23 cid20cid28cid17cid23 cid24cid28cid17cid23 cid20cid17cid24cid19cid3cid11cid19cid17cid21cid28cid177cid21cid17cid26cid19cid12 cid21cid17cid20cid26cid3cid11cid20cid17cid25cid20cid177cid21cid17cid26cid22cid12 cid20cid17cid21cid23cid3cid11cid19cid17cid21cid25cid177cid21cid17cid21cid21cid12 cid20cid17cid26cid27cid3cid11cid20cid17cid20cid25cid177cid21cid17cid23cid19cid12 cid21cid20cid17cid19 cid20cid28cid17cid25 cid23cid19cid17cid25 cid177cid19cid17cid21cid24cid3cid11cid177cid20cid17cid19cid20cid3cid87cid82cid3cid19cid17cid24cid20cid12 cid19cid17cid27cid27cid3cid11cid177cid19cid17cid19cid26cid3cid87cid82cid3cid20cid17cid27cid21cid12 cid19cid17cid21cid27cid3cid11cid177cid19cid17cid27cid21cid3cid87cid82cid3cid20cid17cid22cid27cid12 cid20cid19cid19 cid20cid17cid20cid20cid3cid11cid19cid17cid20cid23cid177cid21cid17cid19cid27cid12 cid177cid23 cid177cid21 cid19 cid21 cid23 cid41cid68cid89cid82cid85cid86cid3cid11cid49cid48cid40cid54cid12 cid41cid68cid89cid82cid85cid86cid3cid11cid70cid82cid81cid87cid85cid82cid79cid12 Figure 7 Metaanalysis randomized controlled trials evaluating effects nMes exercise endurance time Abbreviations NMES neuromuscular electrical stimulation SD standard deviation IV inverse variance CI confidence interval CWT constantwork test SWT shuttle walk test Abdellaoui et al14 Intensity important factor related efficacy NMES muscle strength12 Actually stimulus intensity pooled studies differed greatly However defined maximal tolerance trials Therefore stimulation intensity suitable individualized dosage We emphasis role NMES firstly instead dosedependent response The aggregate results suggested regardless type stimulation significant increases quadricep strength NMES easily achieved spite lack MCID muscle strength COPD patients assess data suggestive clinically meaningful difference5051 In summary overall results proved quadricep strength enhanced significantly NMES The methodology evaluation exercise capacity influence outcome study In Pan et als review21 6MWT included pooled analysis In metaanalysis kinds exercise capacity tests 6MWT SWT CWT included subgroup analysis conducted In order minimize bias WMD pool walking distance SMD pool endurance time Analogously excluded studies141521 avoid variance entry criteria The aggregate random effect NMES walking distance 5153 m 95 CI 20138293 Figure 6 exceeding MCID ranging 2533 m 6MWT distance52 However little information methodological variations performance SWT lack MCID SWT distance compared The overall pooled SMD data NMES endurance time 111 95 CI 014208 Figure 7 indicating NMES resulted beneficial effect exercise tolerance We observed high heterogeneity come different SWT methodologies Incremental SWTs trials endurance SWT The sensitivity responsiveness reproducibility tests same5354 In majority cases included increasing 6MWT longer endurance consider effect sizes favoring NMES control exercise capacity cid54cid39 cid55cid82cid87cid68cid79 cid38cid82cid81cid87cid85cid82cid79 cid48cid72cid68cid81 cid54cid39 cid55cid82cid87cid68cid79 cid58cid72cid76cid74cid75cid87 cid11cid8cid12 cid48cid72cid68cid81cid3cid71cid76cid73cid73cid72cid85cid72cid81cid70cid72 cid44cid57cid15cid3cid85cid68cid81cid71cid82cid80cid15cid3cid28cid24cid8cid3cid38cid44 cid48cid72cid68cid81cid3cid71cid76cid73cid73cid72cid85cid72cid81cid70cid72 cid44cid57cid15cid3cid85cid68cid81cid71cid82cid80cid15cid3cid28cid24cid8cid3cid38cid44 cid54cid87cid88cid71cid92cid3cid82cid85 cid86cid88cid69cid74cid85cid82cid88cid83 cid48cid68cid71cid71cid82cid70cid78cid86cid3cid72cid87cid3cid68cid79cid21cid21 cid54cid76cid79cid79cid72cid81cid3cid72cid87cid3cid68cid79cid21cid24cid15cid21cid25 cid55cid68cid86cid71cid72cid80cid76cid85cid3cid72cid87cid3cid68cid79cid21cid22 cid57cid76cid72cid76cid85cid68cid3cid72cid87cid3cid68cid79cid21cid26 cid49cid48cid40cid54 cid48cid72cid68cid81 cid19cid17cid21cid21 cid177cid20cid19cid17cid21 cid177cid21cid28cid17cid28cid21 cid177cid20cid20 cid22cid17cid27cid24 cid21cid17cid23 cid21cid20cid17cid28cid26 cid28cid17cid24cid22 cid21cid24 cid23cid20 cid20cid22 cid20cid20 cid19cid17cid19cid26 cid177cid20cid20cid17cid23 cid177cid21cid22cid17cid26cid20 cid177cid21 cid22cid17cid27cid24 cid21cid17cid24 cid21cid21cid17cid21cid28 cid28cid17cid24cid22 cid55cid82cid87cid68cid79cid3cid11cid28cid24cid8cid3cid38cid44cid12 cid43cid72cid87cid72cid85cid82cid74cid72cid81cid72cid76cid87cid92cid29cid3τ cid21cid32cid21cid17cid24cid23cid30cid3χ cid21cid32cid25cid17cid27cid20cid15cid3cid71cid73cid32cid22cid3cid11cid51cid32cid19cid17cid19cid27cid12cid30cid3cid44 cid21cid32cid24cid25cid8 cid55cid72cid86cid87cid3cid73cid82cid85cid3cid82cid89cid72cid85cid68cid79cid79cid3cid72cid73cid73cid72cid70cid87cid29cid3cid61cid32cid19cid17cid19cid25cid3cid11cid51cid32cid19cid17cid28cid24cid12 cid28cid19 cid21cid26 cid22cid28 cid20cid23 cid28 cid27cid28 cid22cid28cid17cid26 cid24cid20cid17cid23 cid20cid17cid28 cid26cid17cid19 cid19cid17cid20cid24cid3cid11cid177cid20cid17cid28cid23cid3cid87cid82cid3cid21cid17cid21cid23cid12 cid20cid17cid21cid19cid3cid11cid19cid17cid20cid22cid177cid21cid17cid21cid26cid12 cid177cid25cid17cid21cid20cid3cid11cid177cid21cid21cid17cid28cid20cid3cid87cid82cid3cid20cid19cid17cid23cid28cid12 cid177cid28cid17cid19cid19cid3cid11cid177cid20cid26cid17cid23cid19cid3cid87cid82cid3cid177cid19cid17cid25cid19cid12 cid20cid19cid19 cid177cid19cid17cid19cid26cid3cid11cid177cid21cid17cid23cid23cid3cid87cid82cid3cid21cid17cid22cid19cid12 cid177cid21cid19 cid177cid20cid19 cid19 cid20cid19 cid21cid19 cid41cid68cid89cid82cid85cid86cid3cid11cid49cid48cid40cid54cid12 cid41cid68cid89cid82cid85cid86cid3cid11cid70cid82cid81cid87cid85cid82cid79cid12 Figure 8 Metaanalysis randomized controlled trials evaluating effects nMes st georges respiratory Questionnaire scores Abbreviations NMES neuromuscular electrical stimulation SD standard deviation IV inverse variance CI confidence interval International Journal COPD 201611 submit manuscript wwwdovepresscom Dovepress 2973 Chen et al Dovepress However result metaanalysis NMES associated healthrelated quality life mea sured SGRQ The actual value NMES health related life quality uncertain probably fact SGRQ influenced factors55 Further research required clarify place outcomes This metaanalysis limitations Firstly subgroup analysis small sample size led insufficient evidence Secondly diversity measurement led heterogeneity correspondingly Thirdly NMES different parameter settings programs lead differ ent physiological effects outcomes Therefore research needs standardize technique In conclusion NMES appears effective enhancing quadricep strength exercise capacity moderatetosevere COPD patients Further research needed clarify effect outcomes determine optimal use NMES Acknowledgments The study supported National Natural Sci ence Foundation China NSFC 813111129 Science Technology Project Guangdong Province 2014A020215033 Author contributions LZ contributed study conception design drafting submitted article revising draft critically impor tant intellectual content RC revised draft critically important intellectual content provided final approval version published XL contributed acquisition analysis interpretation data drafting submitted article LG BG contributed acquisition analysis interpretation data WW ZZ YH XC revised draft critically important intellectual content All authors contributed stages study gave final approval version published agree accountable aspects work Disclosure The authors report conflicts work References 1 Global Initiative Chronic Obstructive Lung Disease GOLD Global Strategy Diagnosis Management Prevention COPD Bethesda MD GOLD 2016 2 Narsingam S Bozarth AL Abdeljalil A Updates management stable chronic obstructive pulmonary disease Postgrad Med 2015 1277758770 3 Teo WS Tan WS Chong WF et al Economic burden chronic obstruc tive pulmonary disease Respirology 2012171120126 4 Taivassalo T Hussain SN Contribution mitochondria loco motor muscle dysfunction patients COPD Chest 20161495 13021312 5 Marciniuk DD Brooks D Butcher S et al Optimizing pulmonary rehabilitation chronic obstructive pulmonary disease practical issues Canadian Thoracic Society Clinical practice guideline Can Respir J 2010174159168 6 Spruit MA Troosters T Trappenburg JC Decramer M Gosselink R Exercise training rehabilitation patients COPD current perspective Patient Educ Couns 2004523243248 7 Storer TW Exercise chronic pulmonary disease resistance exercise prescription Med Sci Sports Exerc 2001337 SupplS680S692 8 Aquino G Iuliano E di Cagno A et al Effects combined training vs aerobic training cognitive functions COPD randomized controlled trial Int J Chron Obstruct Pulmon Dis 201611711718 9 Kaymaz D Ergün P Demirci E Demir N Comparison effects neuromuscular electrical stimulation endurance training patients severe chronic obstructive pulmonary disease Tuberk Toraks 2015 63117 10 Vivodtzev I Lacasse Y Maltais F Neuromuscular electrical stimula tion lower limbs patients chronic obstructive pulmonary disease J Cardiopulm Rehabil Prev 20082827991 11 Acqua A Dohnert M Santos L Neuromuscular electrical stimulation Russian current expiratory muscle training patients chronic obstructive pulmonary disease J Phys Ther Sci 201224955959 12 Vivodtzev I Debigare R Gagnon P et al Functional muscular effects neuromuscular electrical stimulation patients severe COPD randomized clinical trial Chest 20121413716725 13 Giavedoni S Deans A McCaughey P Drost E MacNee W Rabinovich RA Neuromuscular electrical stimulation prevents muscle function deterioration exacerbated COPD pilot study Respir Med 20121061014291434 14 Abdellaoui A Prefaut C Gouzi F et al Skeletal muscle effects electrostimulation COPD exacerbation pilot study Eur Respir J 2011384781788 15 Napolis LM Dal Corso S Neder JA Malaguti C Gimenes AC Nery LE Neuromuscular electrical stimulation improves exercise tolerance chronic obstructive pulmonary disease patients better preserved fatfree mass Clinics Sao Paulo 2011663401406 16 Dal Corso S Napolis L Malaguti C et al Skeletal muscle structure function response electrical stimulation moderately impaired COPD patients Respir Med 2007101612361243 17 Vivodtzev I Pepin JL Vottero G et al Improvement quadriceps strength dyspnea daily tasks 1 month electrical stimula tion severely deconditioned malnourished COPD Chest 2006 129615401548 18 Zanotti E Felicetti G Maini M Fracchia C Peripheral muscle strength training bedbound patients COPD receiving mechanical ventila tion effect electrical stimulation Chest 20031241292296 19 BourjeilyHabr G Rochester CL Palermo F Snyder P Mohsenin V Randomised controlled trial transcutaneous electrical muscle stimu lation lower extremities patients chronic obstructive pulmonary disease Thorax 2002571210451049 20 Neder JA Sword D Ward SA Mackay E Cochrane LM Clark CJ Home based neuromuscular electrical stimulation new rehabilita tive strategy severely disabled patients chronic obstructive pulmonary disease COPD Thorax 2002574333337 21 Pan L Guo Y Liu X Yan J Lack efficacy neuromuscular electrical stimulation lower limbs chronic obstructive pulmonary disease patients metaanalysis Respirology 20141912229 22 Maddocks M Nolan CM Man WD et al Neuromuscular electri cal stimulation improve exercise capacity patients severe COPD randomised doubleblind placebocontrolled trial Lancet Respir Med 2016412736 23 Tasdemir F InalInce D Ergun P et al Neuromuscular electrical stimulation adjunct endurance resistance training pulmonary rehabilitation stable chronic obstructive pulmonary disease Expert Rev Respir Med 201594493502 24 Akar O Günay E Ulasli SS et al Efficacy neuromuscular electri cal stimulation patients COPD followed intensive care unit Clin Respir J Epub 2015 Nov 24 2974 submit manuscript wwwdovepresscom Dovepress International Journal COPD 201611 Dovepress neuromuscular electrical stimulation COPD 25 Sillen MJ Franssen FM Vaes AW Delbressine JM Wouters EF Spruit MA Metabolic load strength training NMES individ uals COPD results DICES trial BMC Pulm Med 2014 14146 41 Sillen MJ Speksnijder CM Eterman RM et al Effects neuromus cular electrical stimulation muscles ambulation patients chronic heart failure COPD systematic review English language literature Chest 200913614461 26 Sillen MJ Franssen FM Delbressine JM Vaes AW Wouters EF Spruit MA Efficacy lowerlimb muscle training modalities severely dyspnoeic individuals COPD quadriceps muscle weakness results DICES trial Thorax 2014696525531 27 Vieira PJ Chiappa AM Cipriano GJ Umpierre D Arena R Chiappa GR Neuromuscular electrical stimulation improves clinical physiologi cal function COPD patients Respir Med 20141084609620 28 Greening NJ Williams JE Hussain SF et al An early rehabilitation intervention enhance recovery hospital admission exacerbation chronic respiratory disease randomised controlled trial BMJ 2014349g4315 29 Hutton B CataláLópez F Moher D The PRISMA statement extension systematic reviews incorporating network metaanalysis PRISMA NMA Med Clin Barc 20161476262266 Spanish 30 Liberati A Altman DG Tetzlaff J et al The PRISMA statement reporting systematic reviews metaanalyses studies evalu ate health care interventions explanation elaboration PLoS Med 200967e1000100 31 Moher D Liberati A Tetzlaff J Altman DG Preferred reporting items systematic reviews metaanalyses PRISMA statement J Clin Epidemiol 2009621010061012 32 Euteneuer S Windisch W Suchi S Köhler D Jones PW Schönhofer B Healthrelated quality life patients chronic respiratory fail ure longterm mechanical ventilation Respir Med 20061003 477486 33 Hernandes NA Wouters EF Meijer K Annegarn J Pitta F Spruit MA Reproducibility 6minute walking test patients COPD Eur Respir J 2011382261267 34 Eaton T Young P Nicol K Kolbe J The endurance shuttle walking test responsive measure pulmonary rehabilitation COPD patients Chron Respir Dis 20063139 35 Arnardóttir RH Emtner M Hedenström H Larsson K Boman G Peak exercise capacity estimated incremental shuttle walking test patients COPD methodological study Respir Res 20067127 36 Casaburi R Factors determining constant work rate exercise tolerance COPD role dictating minimal clinically important difference response interventions COPD 200521131136 37 Higgins JP Thompson SG Deeks JJ Altman DG Measuring incon sistency metaanalyses BMJ 20033277414557560 38 Furlan AD Imamura M Dryden T Irvin E Massage low pain updated systematic review framework Cochrane Back Review Group Spine Phila Pa 1976 2009341616691684 39 Furlan AD Pennick V Bombardier C van Tulder M 2009 Updated method guidelines systematic reviews Cochrane Back Review Group Spine Phila Pa 1976 2009341819291941 40 Sillen MJ Wouters EF Franssen FM Meijer K Stakenborg KH Spruit MA Oxygen uptake ventilation symptoms low frequency versus highfrequency NMES COPD pilot study Lung 201118912126 42 Roig M Reid WD Electrical stimulation peripheral muscle function COPD systematic review Respir Med 20091034485495 43 Sillen MJ Janssen PP Akkermans MA Wouters EF Spruit MA The metabolic response resistance training neuromuscular electrical stimulation NMES patients COPD pilot study Respir Med 20081025786789 44 Jones AY Ngai SP HuiChan CW Yu HP Acute effects AcuTENS FEV1 blood βendorphin level chronic obstructive pulmonary disease Altern Ther Health Med 2011175813 45 Wen Q Li N Yu PM Randomized controlled trial effect transcutaneous electrical nerve stimulation dingchuan EXB1 pulmonary function patients COPD acute stage Zhongguo Zhen Jiu 201131297100 Chinese 46 Ngai SP Jones AY HuiChan CW Ko FW Hui DS Effect 4 weeks AcuTENS functional capacity βendorphin level subjects chronic obstructive pulmonary disease randomized controlled trial Respir Physiol Neurobiol 201017312936 47 Lau KS Jones AY A single session AcuTENS increases FEV1 reduces dyspnoea patients chronic obstructive pulmonary disease randomised placebocontrolled trial Aust J Physiother 2008 543179184 48 Guyatt GH Oxman AD Vist GE et al GRADE emerging consensus rating quality evidence strength recommendations BMJ 20083367650924926 49 Atkins D Eccles M Flottorp S et al Systems grading quality evidence strength recommendations I critical appraisal existing approaches BMC Health Serv Res 20044138 50 Wouters EF Minimal clinically important differences COPD body mass index muscle strength COPD 200521149155 51 Beaton DE Bombardier C Katz JN et al Looking important changedifferences studies responsiveness J Rheumatol 2001 282400405 52 Singh SJ Puhan MA Andrianopoulos V et al An official systematic review European Respiratory SocietyAmerican Thoracic Society measurement properties field walking tests chronic respiratory disease Eur Respir J 201444614471478 53 Revill SM Noor MZ Butcher G Ward MJ The endurance shuttle walk test alternative sixminute walk test assessment ambulatory oxygen Chron Respir Dis 201074239245 54 Revill SM Morgan MD Singh SJ Williams J Hardman AE The endurance shuttle walk new field test assessment endurance capacity chronic obstructive pulmonary disease Thorax 1999543 213222 55 Henoch I Strang S Löfdahl CG EkbergJansson A Healthrelated quality life nationwide cohort patients COPD related characteristics Eur Clin Respir J 2016331459 International Journal COPD Publish work journal The International Journal COPD international peerreviewed journal therapeutics pharmacology focusing concise rapid reporting clinical studies reviews COPD Special focus given pathophysiological processes underlying disease intervention programs patient focused education self management protocols Dovepress This journal indexed PubMed Central MedLine CAS The manuscript management completely online includes quick fair peerreview easy use Visit httpwwwdovepresscomtestimonialsphp read real quotes published authors Submit manuscript httpwwwdovepresscominternationaljournalofchronicobstructivepulmonarydiseasejournal International Journal COPD 201611 submit manuscript wwwdovepresscom Dovepress 2975